Background People with advanced ovarian or gastrointestinal cancer may develop
malignant bowel obstruction (MBO). They are able to tolerate limited, if any, oral or enteral …

The concept management of patients with small bowel obstruction (SBO) became more
complicated in 1981 when Bizer and colleagues 1 reported that nonoperative management …

Most children with tumors will require one or more surgical interventions as part of the care
and treatment, including making a diagnosis, obtaining adequate venous access …

Purpose To provide evidence-based recommendations on the management of malignant
bowel obstruction (MBO) for patients with advanced cancer. Methods The Multinational …

Background Malnutrition is a problem in advanced cancer, particularly ovarian cancer where
malignant bowel obstruction (MBO) is a frequent complication. Parenteral nutrition is the …

Introduction Malignant bowel obstruction from peritoneal carcinomatosis affects a significant
proportion of luminal gastrointestinal and ovarian oncology patients, and portends poor long …

Context Somatostatin analogues are commonly used to relieve symptoms in malignant
bowel obstruction (MBO) but are more expensive than other antisecretory agents. Objectives …

Purpose The role of parenteral nutrition in the treatment of malignant bowel obstruction is
underestimated since palliative literature mainly focuses on gastric aspiration, nothing per …

Individual response to medication depends on several factors (age, gender, body weight,
general clinical condition, genetics, diet, hydration status, comorbidities, co-administered …

Background Small bowel obstruction (SBO) is a common diagnosis; however, outcomes of
and risk factors for SBO and malignant bowel obstruction (MBO) surgery are not well …